US Patent Issued to Alnylam Pharmaceuticals on March 31 for "Complement component C5 iRNA compositions and methods of use thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,305, issued on March 31, was assigned to Alnylam Pharmaceuticals Inc. (Cambridge, Mass.).

"Complement component C5 iRNA compositions and methods of use thereof" was invented by Kevin Fitzgerald (Brookline, Mass.), James Butler (Lynnfield, Mass.), Brian Bettencourt (Groton, Mass.), Anna Borodovsky (Melrose, Mass.), Satyanarayana Kuchimanchi (Acton, Mass.), Klaus Charisse (Acton, Mass.), Muthiah Manoharan (Weston, Mass.), Martin A Maier (Belmont, Mass.), Kallanthottathil G. Rajeev (Wayland, Mass.) and Donald Foster (Attleboro, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to iRNA, e.g., double-stranded ribonucleic acid (d...